Strontium Chloride
CAS 10476-85-4
Strontium Chloride (CAS 10476-85-4) is a Phase 4 pharmaceutical compound with 0 bioactivity targets and 42 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Strontium Chloride used for in pharmaceutical contexts?
Strontium Chloride (CAS 10476-85-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Strontium Chloride?
Strontium Chloride has 42 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal pain upper, Constipation, Cough, Diarrhoea, Dizziness. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Strontium Chloride also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Strontium Chloride with EU status "permitted".
What clinical phase is Strontium Chloride in?
Strontium Chloride is rendered with ChEMBL max phase 4 (approved).